BRIEF CO-ADMINISTRATION OF IDELALISIB MAY IMPROVE THE LONG-TERM EFFICACY OF FRONTLINE CHEMOIMMUNOTHERAPY IN CHRONIC LYMPHOCYTIC LEUKAEMIA: 3-YEAR FOLLOW-UP FROM THE RIALTO TRIAL

Hematological Oncology ◽

10.1002/hon.32_2630 ◽

2019 ◽

Vol 37 ◽

pp. 217-218

Author(s):

A. Pettitt ◽

N. Kalakonda ◽

S. Cicconi ◽

C. Murphy ◽

G. Menon ◽

...

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Download Full-text

Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival

British Journal of Haematology ◽

10.1111/bjh.14596 ◽

2017 ◽

Vol 177 (4) ◽

pp. 567-577 ◽

Author(s):

Philip A. Thompson ◽

Francesco Stingo ◽

Michael J. Keating ◽

William G. Wierda ◽

Susan M. O'Brien ◽

...

Keyword(s):

Stem Cell ◽

T Cell ◽

Chronic Lymphocytic Leukaemia ◽

Stem Cell Transplant ◽

Lymphocytic Leukaemia ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Long Term Follow Up

Download Full-text

Long‐term efficacy of first‐line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials

British Journal of Haematology ◽

10.1111/bjh.17984 ◽

2021 ◽

Author(s):

John N. Allan ◽

Tait Shanafelt ◽

Adrian Wiestner ◽

Carol Moreno ◽

Susan M. O’Brien ◽

...

Keyword(s):

Clinical Trials ◽

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Pooled Analysis ◽

Download Full-text

Zanubrutinib for treatment‐naïve and relapsed/refractory chronic lymphocytic leukaemia: long‐term follow‐up of the phase I/II AU‐003 study

British Journal of Haematology ◽

10.1111/bjh.17994 ◽

2021 ◽

Author(s):

Gavin Cull ◽

Jan A. Burger ◽

Stephen Opat ◽

David Gottlieb ◽

Emma Verner ◽

...

Keyword(s):

Phase I ◽

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Long Term Follow Up ◽

Treatment Naïve

Download Full-text

Determination of how many immunoglobulin variable region heavy chain mutations are allowable in unmutated chronic lymphocytic leukaemia – long-term follow up of patients with different percentages of mutations

British Journal of Haematology ◽

10.1111/j.1365-2141.2007.06928.x ◽

2008 ◽

Vol 140 (3) ◽

pp. 320-323 ◽

Author(s):

Terry J. Hamblin ◽

Zadie A. Davis ◽

David G. Oscier

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Heavy Chain ◽

Lymphocytic Leukaemia ◽

Variable Region ◽

Immunoglobulin Variable Region ◽

Long Term Follow Up

Download Full-text

Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up

British Journal of Haematology ◽

10.1111/bjh.14681 ◽

2017 ◽

Vol 181 (5) ◽

pp. 693-695 ◽

Author(s):

Paola Ghione ◽

Elisa Genuardi ◽

Davide Rossi ◽

Daniela Drandi ◽

Barbara Mantoan ◽

...

Keyword(s):

Natural History ◽

Clinical Outcome ◽

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Telomere Shortening ◽

Long Term Follow Up ◽

Download Full-text

Long-term follow-up of a phase 2 trial of single agent lenalidomide in previously untreated patients with chronic lymphocytic leukaemia

British Journal of Haematology ◽

10.1111/bjh.12785 ◽

2014 ◽

Vol 165 (5) ◽

pp. 731-733 ◽

Author(s):

Christine I. Chen ◽

Harminder Paul ◽

Trina Wang ◽

Lisa W. Le ◽

Nimisha Dave ◽

...

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Single Agent ◽

Phase 2 ◽

Phase 2 Trial ◽

Long Term Follow Up

Download Full-text

Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients

British Journal of Haematology ◽

10.1046/j.0007-1048.2001.03296.x ◽

2002 ◽

Vol 116 (3) ◽

pp. 538-548 ◽

Author(s):

Karin Karlsson ◽

Mats Strömberg ◽

Jan Liliemark ◽

André Delannoy ◽

S. A. N. Johnson ◽

...

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

B Cell ◽

Lymphocytic Leukaemia ◽

Phase Ii Trial ◽

Weekly Schedule ◽

Cell Chronic Lymphocytic Leukaemia ◽

Long Term Follow Up ◽

Pretreated Patients

Download Full-text

Long-term efficacy of long-acting somatostatin analogues in combination with pegvisomant in 112 acromegaly patients, a retrospective single centre study with follow up for up to 8 years

Endocrine Abstracts ◽

10.1530/endoabs.32.p855 ◽

2013 ◽

Author(s):

Sanne Franck ◽

der Lely Aart-Jan van ◽

Rijke Yolanda de ◽

Sebastian Neggers

Keyword(s):

Somatostatin Analogues ◽

Single Centre ◽

Centre Study ◽

Term Efficacy ◽

Single Centre Study ◽

Download Full-text

Faculty Opinions recommendation of Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9582962.10243060 ◽

2011 ◽

Author(s):

Carlos Pavesio ◽

Claire Hooper

Keyword(s):

Behçet’S Disease ◽

Behcet’S Disease ◽

Behçet's Disease ◽

Posterior Uveitis ◽

Behcet's Disease ◽

Follow Up Study ◽

Download Full-text

Long‐term efficacy and safety of risankizumab for the treatment of moderate‐to‐severe plaque psoriasis: interim analysis of the LIMMitless open‐label extension trial beyond 3 years of follow‐up

British Journal of Dermatology ◽

10.1111/bjd.20595 ◽

2021 ◽

Author(s):

K.A. Papp ◽

M.G. Lebwohl ◽

L. Puig ◽

M. Ohtsuki ◽

S. Beissert ◽

...

Keyword(s):

Plaque Psoriasis ◽

Interim Analysis ◽

Efficacy And Safety ◽

Severe Plaque Psoriasis ◽

Term Efficacy ◽

Open Label Extension ◽

Extension Trial

Download Full-text